TNGX Cash & Equivalents
Tango Therapeutics Inc · Cash & Equivalents
TNGX Cash & Equivalents
Latest reported$112.28Mperiod ending
TNGX FY Cash & Equivalents ($22.89M → $112.28M)
Annual Cash & Equivalents
High-resolution chart · PNG
TNGX cash & equivalents history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 112,279,000 | |
| 69,530,000 | |
| 66,385,000 | |
| 59,968,000 | |
| 142,745,000 | |
| 28,381,000 | |
| 22,889,000 |